Cynosure Group LLC Buys 3,050 Shares of Exponent, Inc. (NASDAQ:EXPO)

Cynosure Group LLC raised its position in Exponent, Inc. (NASDAQ:EXPOFree Report) by 77.5% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 6,987 shares of the business services provider’s stock after buying an additional 3,050 shares during the period. Cynosure Group LLC’s holdings in Exponent were worth $805,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Inspire Advisors LLC grew its position in shares of Exponent by 1.3% during the 2nd quarter. Inspire Advisors LLC now owns 7,615 shares of the business services provider’s stock worth $724,000 after buying an additional 98 shares during the period. Caprock Group LLC boosted its position in shares of Exponent by 4.2% in the 2nd quarter. Caprock Group LLC now owns 3,296 shares of the business services provider’s stock worth $314,000 after purchasing an additional 134 shares during the last quarter. GAMMA Investing LLC increased its holdings in Exponent by 67.7% in the second quarter. GAMMA Investing LLC now owns 379 shares of the business services provider’s stock valued at $36,000 after purchasing an additional 153 shares during the last quarter. Raymond James Trust N.A. increased its holdings in Exponent by 2.8% in the second quarter. Raymond James Trust N.A. now owns 6,230 shares of the business services provider’s stock valued at $593,000 after purchasing an additional 172 shares during the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in Exponent by 11.0% in the second quarter. Parkside Financial Bank & Trust now owns 2,008 shares of the business services provider’s stock valued at $191,000 after buying an additional 199 shares during the period. Institutional investors own 92.37% of the company’s stock.

Exponent Price Performance

Shares of EXPO stock opened at $98.99 on Wednesday. The stock has a 50-day moving average of $106.17 and a 200-day moving average of $102.22. Exponent, Inc. has a one year low of $68.70 and a one year high of $115.75. The stock has a market cap of $5.02 billion, a PE ratio of 47.82 and a beta of 0.69.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.13%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s dividend payout ratio (DPR) is 54.11%.

Insider Activity at Exponent

In other news, Director Paul R. Johnston sold 14,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the transaction, the director now owns 80,742 shares in the company, valued at $8,445,613.20. This represents a 14.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of the firm’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the sale, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. The trade was a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 30,339 shares of company stock worth $3,103,065 in the last quarter. Corporate insiders own 2.10% of the company’s stock.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.